Back | Next |
home / stock / agn / agn message board
Subject | By | Source | When |
---|---|---|---|
RF-frequency devices for aesthetic applications go back at | DewDiligence | investorshub | 06/24/2019 6:41:34 PM |
The Zeltiq device is cryogenic and seems to | semi_infinite | investorshub | 06/24/2019 6:17:52 PM |
whytestocks: $AGN News Article - Stocks Gain After Fed Meeting | whytestocks | investorshangout | 06/19/2019 8:40:43 PM |
~ 60% more effective then laser removal. Shorter | RichardSawars | investorshub | 05/11/2019 9:06:21 PM |
I would question the business plan of any | DewDiligence | investorshub | 05/11/2019 9:03:00 PM |
In regards to $AGN.. Has anyone heard of | RichardSawars | investorshub | 05/11/2019 3:21:25 PM |
$AGN 1Q19 CC transcript: | DewDiligence | investorshub | 05/08/2019 3:13:34 PM |
$AGN 1Q19 CC slides: | DewDiligence | investorshub | 05/07/2019 2:49:01 PM |
(From $AGNs PR)1Q19 worldwide Botox sales=$868.4M, +6% YoY | DewDiligence | investorshub | 05/07/2019 2:45:24 PM |
$AGN 1Q19 results: | DewDiligence | investorshub | 05/07/2019 2:45:06 PM |
whytestocks: $AGN News Article - Allergan to Showcase Continued Eye Care Innovation with New Data at | whytestocks | investorshangout | 04/25/2019 7:45:40 PM |
whytestocks: $AGN News Article - Allergan launches Juv derm VOLUX - the latest evolution in facial f | whytestocks | investorshangout | 04/04/2019 7:30:40 PM |
Abicipar pegol (a/k/a DARPin) shows 8.9% ocular inflammation | DewDiligence | investorshub | 04/02/2019 1:42:23 PM |
Three phase-3 Rapastinel trials stopped for futility: | DewDiligence | investorshub | 03/06/2019 10:56:23 PM |
$AGN 4Q18 CC transcript: | DewDiligence | investorshub | 01/30/2019 2:08:49 PM |
$AGN 4Q18 CC slides: | DewDiligence | investorshub | 01/29/2019 1:58:24 PM |
$AGN 4Q18 results: | DewDiligence | investorshub | 01/29/2019 1:23:17 PM |
News: $AGN CoolSculpting® and Sonja Morgan Partner To | whytestocks | investorshub | 01/15/2019 5:16:24 PM |
$AGN -7% on permanent recall of textured breast | DewDiligence | investorshub | 12/19/2018 6:55:56 PM |
$AGN 3Q18 CC transcript: | DewDiligence | investorshub | 10/30/2018 6:48:41 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-03-27 17:08:02 ET About to begin a phase 2b/3 multinational study of Ifenprodil Algernon Pharmaceuticals is a drug repurposing company. They're a phase 2 clinical stage company advancing a drug called Ifenprodil for idiopathic pulmonary fibrosis, but also as a potential thera...
2024-03-27 17:08:02 ET A stroke can be a devastating and debilitating event for an individual and their family, and a major burden on the health care system. Over 15 million people suffer strokes every year, and 85% of those have some form of disability as a result. Stroke-related cos...
2024-03-27 17:08:02 ET Stocks to Invest in: Healthcare Focused on the disease areas of stroke, idiopathic pulmonary fibrosis (IPF) & chronic cough, and chronic kidney disease Algernon is a drug re-purposing company that investigates safe, already approved drugs, inclu...